Project Inform - September, 1998

Abacavir (NARTI) 800-501-4672

• For anyone failing current therapy and requiring an additional new drug for treatment strategy.

• For anyone failing current therapy and requiring an additional new drug for treatment strategy.

• As PI Perspective 25 goes to print, an amprenavir expanded access program is being reviewed by the FDA. For new information about this program, contact the National HIV/AIDS Treatment Hotline at 800-822-7422.

• For anyone failing current therapy whose CD4+ cell count has ever gone below 400 and requires an additional new drug for treatment strategy.

980901
PI980914

©1998. This document is copyrighted by Project Inform, 205 13th Street, #2001, San Francisco, CA 94103. Treatment Hotline: 800-822-7422 (toll-free) or 415-558-9051 (in the San Francisco Bay Area and internationally) All Project Inform materials may be reprinted and/or distributed without prior permission. However, reprints may not be edited and must include the following text: "From Project Inform, for more information contact the Project Inform National HIV/AIDS Treatment Hotline, 800-822-7422." For permission to edit any Project Inform material for further publication, contact David Evans at the Project Inform office.

Project Inform, established in 1985 as a national, non profit, community-based HIV/AIDS treatment information and advocacy organization, serves HIV-infected individuals, their care-givers, and their healthcare and service providers through its national, toll-free treatment hotline, the PI Perspective and other information publications, educational Town Meetings, on-line services and research and drug access advocacy programs. All information is available free of charge; donations are strongly encouraged. For more information, contact the Project Inform National HIV/AIDS Treatment Hotline. Email: web@projinf.org; Website: http://www.projinf.org.

The original of this article can be found at http://www.projinf.org/pub/25/newdrugs.html